Appendix A. Relapses by Clinical Stage
Clinical Stage |
Type of Relapse |
Relapse Rate |
Reference |
IA |
L |
0.45% |
[Urist 1985; Schmid-Wendtner 2003] [Balch 2001]? |
LN |
2% |
[Rousseau 2003] |
|
macroscopic = 2% |
[Balch 1980 ; Balch 2001] |
||
S |
1.59% |
[Kang 2005]? (Calc Balch) [Balch 2001] |
|
M |
2.1% |
[Balch 1980 ; Balch 2001] |
|
IB |
L |
1.48% ↑ |
[Urist 1985; Schmid-Wendtner 2003] [Balch 2001] |
LN |
9%; ↑S |
[Rousseau 2003] |
|
macroscopic = 18.18% |
[Balch 1980 ; Balch 2001] |
||
S |
3.16%↑ |
[Kang 2005] [Balch 2001] |
|
M |
6.52% ↑ |
[Balch 1980 ; Balch 2001] |
|
IIA |
L |
4.86% ↑ |
[Urist 1985] [Balch 2001] |
LN |
24% ↑S
|
[Rousseau 2003] |
|
macroscopic 45.53% ↑ |
[Balch 1980 ; Balch 2001] |
||
S |
7.16% ↑ |
[Kang 2005] [Balch 2001] |
|
M |
12.49% ↑ |
[Balch 1980 ; Balch 2001] |
|
IIB |
L |
8.23% ↑ |
[Urist 1985] [Balch 2001] |
LN |
3.4% ↑S |
[Rousseau 2003] |
|
macroscopic 58.34% |
[Balch 1980 ; Balch 2001] |
||
S |
9.00% ↑ |
[Kang 2005] [Balch 2001] |
|
M |
30.37%↑ |
[Balch 1980 ; Balch 2001] |
|
IIC |
L |
13.2% ↑ |
[Urist 1985] [Balch 2001] |
LN |
53%; ↑S |
[Rousseau 2003] |
|
macroscopic 62% |
[Balch 1980 ; Balch 2001] |
||
S |
8.95% |
[Kang 2005] [Balch 2001] |
|
M |
72% ↑ |
[Balch 1980 ; Balch 2001] |
|
IIIA |
L |
15.7% ↑ |
[Fincher 2003; Calabro 1989] |
LN |
14% ↓ |
[Pidhorecky 2001; Fincher 2003] |
|
S |
27% ↑ |
[Calabro 1989] |
|
M |
66.8% |
[Calabro 1989] |
|
IIIB |
L |
15.6% |
[Calabro 1989] |
LN |
20.65% ↑ |
[Pidhorecky 2001] [Balch 2001] |
|
S |
17% |
[Calabro 1989] |
|
M |
67.4% ↑ |
[Calabro 1989] |
|
IIIC |
L |
15.6% |
[Calabro 1989] |
LN |
28% after TLND ↑ |
[Pidhorecky 2001] |
|
S |
12.9% |
[Calabro 1989] |
|
M |
76.7% ↑ |
[Calabro 1989] |
L = local; LN = lymph node; S = satellite/in-transit; M = metastasis; PALP = palpable; TLND = total lymph-node dissection.